Pfizer is ready to enroll about 4,500 young volunteers at more than 90 sites in the U.S., Finland, Poland and Spain.
NEW YORK — Pfizer says it is expanding testing of its COVID-19 vaccine in children younger than 12.The vaccine made by Pfizer and its German partner BioNTech already is authorized for emergency use in anyone 12 and older in the U.S. and European Union.
Enrollment of 5- to 11-year-olds began this week. Those youngsters will receive two vaccine doses of 10 micrograms each ― a third of the teen and adult dose ― or dummy shots. Enrollment of children as young as 6 months will start in a few weeks using an even lower dose, 3 micrograms per shot.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer advances clinical trials for 5- to 11-year-olds at lower doses
Read more »
Covid-19 Vaccines for Young Children Move Ahead in TestingPfizer and BioNTech have begun a pivotal study testing their shot in children under 12 years old, while Moderna is aiming for results from testing in kids 5 years and older in the fall.
Read more »
Pfizer advances clinical trials for 5- to 11-year-olds at lower doses
Read more »
US surpasses 300 million COVID-19 vaccine shots administeredThe U.S. Centers for Disease Control and Prevention announced that over 300 million vaccines doses have so far been administered across the country. The Pfizer vaccine is currently eligible for Americans over the age of 12, while the Moderna and Johnson & Johnson vaccines are eligible for Americans over 16. As of Sunday, roughly 49.3% of the U.S. population over 12 is fully vaccinated, the CDC said.
Read more »